HOXD12 defines an age-related aggressive subtype of oligodendroglioma

2024-9-11

Autophagy–lysosomal-associated neuronal death in neurodegenerative disease

2024-9-11

Multiciliated ependymal cells: an update on biology and pathology in the adult brain

2024-9-10

Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance

2024-9-10

Novel mutation of SMPX-related scapuloperoneal myopathy and myofibrillar myopathy

2024-9-4

Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer’s disease continuum

2024-9-3

Rapid brain lymphoma diagnostics through nanopore sequencing of cytology-negative cerebrospinal fluid

2024-9-3

Glioblastoma, IDH-wildtype with primarily leptomeningeal localization diagnosed by nanopore sequencing of cell-free DNA from cerebrospinal fluid

2024-9-3

Disability independent of cerebral white matter demyelination in progressive multiple sclerosis

2024-8-31

Histopathologic correlates of opioid-associated injury in CHANTER syndrome: first report of a post-mortem examination

2024-8-31

PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease

2024-8-29

Inflammatory aspects of Alzheimer’s disease

2024-8-28

Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rate

2024-8-27

Methylation profiling of plasma cell-free DNA in pediatric brain tumor patients

2024-8-26

The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas

2024-8-23

Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups

2024-8-23

FGFR1 wild-type rosette-forming glioneuronal tumours

2024-8-21

Severe neurodegeneration in brains of transgenic rats producing human tau prions

2024-8-20

Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases

2024-8-19

Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1”

2024-8-16

Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease

2024-8-16

Key features of choroidal abnormalities in neurofibromatosis type 1, a commentary on “Histologic correlates of “choroidal abnormalities” in neurofibromatosis type 1 (NF1)”

2024-8-16

Cryo-EM structures of cotton wool plaques’ amyloid β and of tau filaments in dominantly inherited Alzheimer disease

2024-8-15

Current insights and assumptions on α-synuclein in Lewy body disease

2024-8-14

ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors

2024-8-14

Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma

2024-8-8

Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome

2024-8-6

Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease

2024-8-5

Alcohol consumers with liver pathology rarely display α-synuclein pathology

2024-8-1

The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy

2024-8-1

Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4

2024-7-29

High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains

2024-7-25

Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease

2024-7-24

Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment

2024-7-22

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

2024-7-18

Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations

2024-7-18

Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma

2024-7-16

Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy

2024-7-16

DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson’s disease, and progressive supranuclear palsy: a cross-comparative investigation

2024-7-12

Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases

2024-7-9

Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status

2024-7-9

Chronic traumatic encephalopathy (CTE) in the context of longstanding intimate partner violence

2024-7-8

Annexin A11 aggregation in FTLD–TDP type C and related neurodegenerative disease proteinopathies

2024-6-1

Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progression

2024-6-1

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis

2024-6-1

Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus

2024-6-1

Ferroptosis inhibitor improves outcome after early and delayed treatment in mild spinal cord injury

2024-6-1

Xenografted human iPSC-derived neurons with the familial Alzheimer’s disease APPV717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator

2024-6-1

Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations

2024-6-1

Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease

2024-6-1